Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review

[1]  I. Hertz-Picciotto,et al.  Prenatal SSRI Use and Offspring With Autism Spectrum Disorder or Developmental Delay , 2014, Pediatrics.

[2]  Whitney M. Weikum,et al.  The impact of prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and maternal mood on mother-infant interactions at 3 months of age. , 2013, Infant behavior & development.

[3]  D. Schendel,et al.  Antidepressant exposure in pregnancy and risk of autism spectrum disorders , 2013, Clinical epidemiology.

[4]  M. Austin,et al.  Infant neurodevelopment following in utero exposure to antidepressant medication , 2013, Acta paediatrica.

[5]  Whitney M. Weikum,et al.  Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and serotonin transporter promoter genotype (SLC6A4) influence executive functions at 6 years of age , 2013, Front. Cell. Neurosci..

[6]  T. Frøslev,et al.  In utero exposure to antidepressant drugs and risk of attention deficit hyperactivity disorder: a nationwide Danish cohort study , 2013, BMJ Open.

[7]  Paige L. Williams,et al.  Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States , 2013, BMJ.

[8]  T. Oberlander,et al.  Antidepressant use during pregnancy and serotonin transporter genotype (SLC6A4) affect newborn serum reelin levels. , 2013, Developmental psychobiology.

[9]  A. Concheiro-Guisán,et al.  Maternal Hair Analysis for the Detection of Illicit Drugs, Medicines, and Alcohol Exposure During Pregnancy , 2013, Therapeutic drug monitoring.

[10]  A. Bos,et al.  Early Neurological Outcome of Young Infants Exposed to Selective Serotonin Reuptake Inhibitors during Pregnancy: Results from the Observational SMOK Study , 2013, PloS one.

[11]  J. Kuint,et al.  Short-Term Neonatal Outcome among Term Infants after in utero Exposure to Serotonin Reuptake Inhibitors , 2013, Neonatology.

[12]  P. Andersen,et al.  Maternal depression, antidepressant use in pregnancy and Apgar scores in infants , 2013, British Journal of Psychiatry.

[13]  C. Reid,et al.  Perturbations in cortical development and neuronal network excitability arising from prenatal exposure to benzodiazepines in mice , 2013, The European journal of neuroscience.

[14]  Brian K. Lee,et al.  Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study , 2013, BMJ : British Medical Journal.

[15]  Megan V. Smith,et al.  Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors. , 2013, Early human development.

[16]  J. Olsen,et al.  Prenatal antidepressant exposure and behavioral problems in early childhood – a cohort study , 2013, Acta psychiatrica Scandinavica.

[17]  D. Streiner,et al.  Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. , 2012, The American journal of psychiatry.

[18]  Takao K Hensch,et al.  Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception , 2012, Proceedings of the National Academy of Sciences.

[19]  B. Källén,et al.  Neonatal Complications After Maternal Concomitant Use of SSRI and Other Central Nervous System Active Drugs During the Second or Third Trimester of Pregnancy , 2012, Journal of clinical psychopharmacology.

[20]  A. Sjölander,et al.  Sibling comparison designs: bias from non-shared confounders and measurement error. , 2012, Epidemiology.

[21]  G. Aylward,et al.  In Utero Antidepressant Exposure and Neurodevelopment in Preterm Infants , 2012, American Journal of Perinatology.

[22]  T. Oberlander,et al.  Third trimester fetal pulmonary artery Doppler blood flow velocity characteristics following prenatal selective serotonin reuptake inhibitor (SSRI) exposure. , 2012, Early human development.

[23]  Sabine J. Roza,et al.  Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. , 2012, Archives of general psychiatry.

[24]  T. Einarson,et al.  Pregnancy Outcomes Following Use of Escitalopram: A Prospective Comparative Cohort Study , 2012, Journal of clinical pharmacology.

[25]  P. Reebye,et al.  Affect Expression and Self-Regulation Capacities of Infants Exposed in utero to Psychotropics , 2012, Front. Psychiatry.

[26]  C. Dennis,et al.  Quality assessment of observational studies in psychiatry: an example from perinatal psychiatric research , 2011, International journal of methods in psychiatric research.

[27]  Cathleen K. Yoshida,et al.  Antidepressant use during pregnancy and childhood autism spectrum disorders. , 2011, Archives of general psychiatry.

[28]  Amy L. Salisbury,et al.  Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment , 2011, Depression and anxiety.

[29]  R. Nielsen,et al.  Paediatric outcomes following intrauterine exposure to serotonin reuptake inhibitors: a systematic review. , 2011, Danish medical bulletin.

[30]  J. Homberg,et al.  The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: A review , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[31]  G. Li Volti,et al.  Antenatal maternal antidepressants drugs affect Activin A concentrations in maternal blood, in amniotic fluid and in fetal cord blood , 2011, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[32]  M. Gissler,et al.  Selective Serotonin Reuptake Inhibitors and Risk for Major Congenital Anomalies , 2011, Obstetrics and gynecology.

[33]  L. Altshuler,et al.  A prospective, naturalistic, blinded study of early neurobehavioral outcomes for infants following prenatal antidepressant exposure. , 2011, The Journal of clinical psychiatry.

[34]  A. Buist,et al.  Developmental Outcomes of Children Exposed to Antidepressants in Pregnancy , 2011, The Australian and New Zealand journal of psychiatry.

[35]  K. Verhamme,et al.  Study designs in paediatric pharmacoepidemiology , 2011, European Journal of Clinical Pharmacology.

[36]  L. Lazzeroni,et al.  Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development , 2011, Psychopharmacology.

[37]  G. Diamond,et al.  Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome , 2011, Journal of Perinatology.

[38]  S. Rasmussen,et al.  Patterns of Antidepressant Medication Use Among Pregnant Women in a United States Population , 2011, Journal of clinical pharmacology.

[39]  M. Gissler,et al.  Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries , 2011, BMJ : British Medical Journal.

[40]  Z. Cong,et al.  Discontinuation syndrome in newborns whose mothers took antidepressants while pregnant or breastfeeding. , 2010, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

[41]  W. Katon,et al.  Depressive Disorders During Pregnancy: Prevalence and Risk Factors in a Large Urban Sample , 2010, Obstetrics and gynecology.

[42]  R. Figueroa.  Use of Antidepressants During Pregnancy and Risk of Attention-Deficit/Hyperactivity Disorder in the Offspring , 2010, Journal of developmental and behavioral pediatrics : JDBP.

[43]  R. Grunau,et al.  Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age. , 2010, Archives of pediatrics & adolescent medicine.

[44]  J. Olsen,et al.  Fetal Exposure to Antidepressants and Normal Milestone Development at 6 and 19 Months of Age , 2010, Pediatrics.

[45]  P. Gaspar,et al.  New perspectives on the neurodevelopmental effects of SSRIs. , 2010, Trends in pharmacological sciences.

[46]  A. Czeizel,et al.  Congenital abnormalities in children of 43 pregnant women who attempted suicide with large doses of nitrazepam , 2010, Pharmacoepidemiology and drug safety.

[47]  D. Siscovick,et al.  Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy , 2010 .

[48]  Wilhelmina S Kerstjens-Frederikse,et al.  First-trimester use of paroxetine and congenital heart defects: a population-based case-control study. , 2009, Birth defects research. Part A, Clinical and molecular teratology.

[49]  T. Henriksen,et al.  Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. , 2009, Archives of pediatrics & adolescent medicine.

[50]  J. Lum,et al.  Serotonin Discontinuation Syndrome Following in Utero Exposure to Antidepressant Medication: Prospective Controlled Study , 2009, The Australian and New Zealand journal of psychiatry.

[51]  R. Bakeman,et al.  Caregiving behavior and interactions of prenatally depressed mothers (antidepressant-treated and non-antidepressant-treated) during newborn acute pain. , 2009, Infant mental health journal.

[52]  A. Coenen,et al.  Placental Transfer of SSRI and SNRI Antidepressants and Effects on the Neonate , 2009, Pharmacopsychiatry.

[53]  A. Berrebi,et al.  Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database , 2009, European Journal of Clinical Pharmacology.

[54]  Abraham Weizman,et al.  Effect of Exposure to Selective Serotonin Reuptake Inhibitors In Utero on Fetal Growth: Potential Role for the IGF-I and HPA Axes , 2009, Pediatric Research.

[55]  R. Grunau,et al.  Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure. , 2008, Early human development.

[56]  Mark Olfson,et al.  Psychiatric disorders in pregnant and postpartum women in the United States. , 2008, Archives of general psychiatry.

[57]  A. Bairam,et al.  A New Look at the Neonate's Clinical Presentation After In Utero Exposure to Antidepressants in Late Pregnancy , 2008, Journal of clinical psychopharmacology.

[58]  Paul B van den Berg,et al.  Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. , 2008, British journal of clinical pharmacology.

[59]  R. Platt,et al.  Use of antidepressant medications during pregnancy: a multisite study. , 2008, American journal of obstetrics and gynecology.

[60]  N. Ács,et al.  An evaluation of data for 10 children born to mothers who attempted suicide by taking large doses of alprazolam during pregnancy , 2008, Toxicology and industrial health.

[61]  A. Czeizel,et al.  A study of the effects of large doses of medazepam used for self-poisoning in 10 pregnant women on fetal development , 2008, Toxicology and industrial health.

[62]  S. Goodman.  Depression in mothers. , 2007, Annual review of clinical psychology.

[63]  A. Egberts,et al.  Indications for antidepressant drug prescribing in general practice in the Netherlands. , 2007, Journal of affective disorders.

[64]  L. Ross,et al.  Anxiety disorders during pregnancy and the postpartum period: A systematic review. , 2006, The Journal of clinical psychiatry.

[65]  L. Jong‐van den Berg,et al.  Prevalence and patterns of antidepressant drug use during pregnancy , 2006, European Journal of Clinical Pharmacology.

[66]  P. Reebye,et al.  Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. , 2006, The American journal of psychiatry.

[67]  S. Hernández-Díaz,et al.  Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn , 2006, The New England journal of medicine.

[68]  M. Owens,et al.  Placental Passage of Tricyclic Antidepressants , 2006, Biological Psychiatry.

[69]  B. Vandermeer,et al.  Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis , 2006, BMJ : British Medical Journal.

[70]  Yehezkel Ben-Ari,et al.  Trophic actions of GABA on neuronal development , 2005, Trends in Neurosciences.

[71]  R. Grunau,et al.  Pain Reactivity in 2-Month-Old Infants After Prenatal and Postnatal Selective Serotonin Reuptake Inhibitor Medication Exposure , 2005, Pediatrics.

[72]  Robert L Davis,et al.  Prescription drug use in pregnancy. , 2004, American journal of obstetrics and gynecology.

[73]  B. Källén.  Neonate characteristics after maternal use of antidepressants in late pregnancy. , 2004, Archives of pediatrics & adolescent medicine.

[74]  T. Einarson,et al.  Prevalence of Depression During Pregnancy: Systematic Review , 2004, Obstetrics and gynecology.

[75]  T. Oberlander,et al.  Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. , 2004, The Journal of clinical psychiatry.

[76]  H. Hoyme,et al.  Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. , 2003, The Journal of pediatrics.

[77]  D. Kupfer,et al.  Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review , 2003, The Lancet.

[78]  D. Stewart,et al.  Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. , 2002, The American journal of psychiatry.

[79]  J. Olsen,et al.  Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics , 2002, European Journal of Epidemiology.

[80]  R. Grunau,et al.  Prolonged Prenatal Psychotropic Medication Exposure Alters Neonatal Acute Pain Response , 2002, Pediatric Research.

[81]  E. Frank,et al.  Risk-benefit decision making for treatment of depression during pregnancy. , 2000, The American journal of psychiatry.

[82]  I. Gotlib,et al.  Risk for psychopathology in the children of depressed mothers: a developmental model for understanding mechanisms of transmission. , 1999, Psychological review.

[83]  B. B. Little,et al.  Pharmacokinetics during pregnancy: evidence-based maternal dose formulation. , 1999, Obstetrics and gynecology.

[84]  A. Czeizel,et al.  The effect of diazepam and promethazine treatment during pregnancy on the somatic development of human offspring. , 1999, Neurotoxicology and teratology.

[85]  T. Einarson,et al.  Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies , 1998, BMJ.

[86]  A. Ornoy,et al.  Is benzodiazepine use during pregnancy really teratogenic? , 1998, Reproductive toxicology.

[87]  J. Noordhoek,et al.  Mechanisms of drug transfer across the human placenta. , 1998, Pharmacy World and Science.

[88]  N. Black,et al.  The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. , 1998, Journal of epidemiology and community health.

[89]  J. Harvey,et al.  New evidence for neurotransmitter influences on brain development , 1997, Trends in Neurosciences.

[90]  G. Koren,et al.  Neurodevelopment of children exposed in utero to antidepressant drugs , 1997, The New England journal of medicine.

[91]  K. Jones,et al.  Birth outcomes in pregnant women taking fluoxetine. , 1996, New England Journal of Medicine.

[92]  M. O’Hara,et al.  Rates and risk of postpartum depression—a meta-analysis , 1996 .

[93]  M. Druse,et al.  Serotonin as a developmental signal , 1995, Behavioural Brain Research.

[94]  M. Bonati,et al.  Use of psychotropic drugs during pregnancy , 1993, European Journal of Clinical Pharmacology.

[95]  J. Lauder,et al.  Neurotransmitters as growth regulatory signals: role of receptors and second messengers , 1993, Trends in Neurosciences.

[96]  G. Viggedal,et al.  Mental development in late infancy after prenatal exposure to benzodiazepines--a prospective study. , 1993, Journal of child psychology and psychiatry, and allied disciplines.

[97]  G. Hagberg,et al.  Neurodevelopment in Late Infancy After Prenatal Exposure to Benzodiazepines - A Prospective Study* , 1992, Neuropediatrics.

[98]  G. Hagberg,et al.  The Effect of Benzodiazepines on the Fetus and the Newborn* , 1992, Neuropediatrics.

[99]  O. Vinař,et al.  Effects of drug administration in pregnancy on children's school behaviour , 1990, Pharmaceutisch Weekblad.

[100]  H. Bauchner,et al.  Depressive symptoms during pregnancy: Relationship to poor health behaviors , 1989, American journal of obstetrics and gynecology.

[101]  L. Milkovich,et al.  Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development. , 1974, The New England journal of medicine.

[102]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[103]  L. de Jong-van den Berg,et al.  Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 2: Testing the hypotheses. , 2012, British journal of clinical pharmacology.

[104]  S. Morgan,et al.  Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006). , 2012, Clinical therapeutics.

[105]  A. Sjölander,et al.  Sibling Comparison Designs Bias From Non-Shared Confounders and Measurement Error , 2012 .

[106]  C. Dunkel Schetter,et al.  Psychological science on pregnancy: stress processes, biopsychosocial models, and emerging research issues. , 2011, Annual review of psychology.

[107]  K. Wisner,et al.  Changes in antidepressant metabolism and dosing across pregnancy and early postpartum. , 2008, The Journal of clinical psychiatry.

[108]  K. Olkkola,et al.  Midazolam and other benzodiazepines. , 2008, Handbook of experimental pharmacology.

[109]  L. Shulman.  Increasing use of antidepressants in pregnancy , 2008 .

[110]  J. Dungan.  Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects , 2008 .

[111]  P. Reebye,et al.  Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. , 2007, Archives of pediatrics & adolescent medicine.

[112]  R. Ehrenkranz.  Neonatal Outcomes After Prenatal Exposure to Selective Serotonin Reuptake Inhibitor Antidepressants and Maternal Depression Using Population-Based Linked Health Data , 2007 .

[113]  S. Goodman,et al.  Women and Depression: Depression in Women Who Are Mothers , 2006 .

[114]  S. Goodman,et al.  Women and Depression: List of Contributors , 2006 .

[115]  M. Neal.  Medical Pharmacology at a Glance , 1987 .

[116]  A. Hordern.  Depressive disorders. , 1974, The Practitioner.